Prospective Study of EndoAim: ASUS AI Solution for Colorectal Polyp Diagnosis
Launched by WEN-HSIN HUANG · Oct 22, 2024
Trial Information
Current as of August 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new technology called the ASUS AI-assisted system (EndoAim) to see if it can help doctors find polyps during colonoscopy, which is a common procedure to check for colorectal cancer. Colorectal cancer is a serious health issue, and this study is important because many polyps can be missed during routine screenings. The goal is to compare the results of colonoscopies done with and without the AI system to see if it improves the detection of polyps that could lead to cancer.
To participate in this trial, you need to be at least 20 years old and scheduled for a colonoscopy using specific equipment. You should also follow a low-residue diet and prepare your bowels beforehand. If you join, you'll be randomly assigned to have a colonoscopy with the AI system or without it, and the doctors will closely monitor how well the AI helps in finding polyps. This study is currently recruiting participants, and your health will be carefully evaluated throughout the process to ensure the best outcomes.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Age 20 or older.
- • 2. Undergoing colonoscopy using the Olympus series endoscopes.
- • 3. Following a low-residue diet and undergoing bowel preparation.
- Exclusion Criteria:
- • 1. Poor bowel cleansing. Note: Evaluated as Poor or Inadequate according to the Aronchick scale.
- • 2. Incomplete colonoscopy (not reaching the cecum).
- • 3. Use of anticoagulant medications or abnormal coagulation function within the last 5 days.
About Wen Hsin Huang
Wen-Hsin Huang is a dedicated clinical trial sponsor with a focus on advancing innovative medical research and improving patient outcomes. With a robust background in clinical science and a commitment to ethical research practices, Wen-Hsin Huang oversees the design, implementation, and management of clinical trials across various therapeutic areas. The organization emphasizes collaboration with leading researchers and institutions to ensure the highest standards of scientific integrity and regulatory compliance. By fostering a patient-centered approach, Wen-Hsin Huang strives to contribute meaningful advancements in healthcare through the successful development of new therapies and treatments.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taichung, , Taiwan
Taichung, North Dist., Taiwan
Patients applied
Trial Officials
Wen-Hsin Huang, MD
Principal Investigator
China Medical University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported